Educational information only. Realvigor does not diagnose or replace medical care.
Medication vs procedure

Finasteride vs Rezūm for BPH

Compare finasteride with Rezūm for BPH by prostate-size strategy, daily medication, recovery, durability and sexual-function trade-offs.

Direct answer: Finasteride and Rezūm solve BPH in different ways. Finasteride is a daily 5-alpha-reductase inhibitor that reduces DHT and can shrink enlarged prostate tissue over time. Rezūm is a procedure intended to relieve obstruction without relying on the same long-term hormonal mechanism. The decision depends on anatomy, symptom severity, medication response, side effects, durability goals and the sexual outcomes that matter to you.

Medication versus procedure

Finasteride is a long-term medication strategy. A procedure changes the anatomy or tissue causing obstruction and introduces procedure-specific candidacy, recovery and adverse-event considerations.

The relevant question is not which option is “stronger.” It is whether continued disease-modifying medication or a procedural approach better fits the symptoms, prostate anatomy and treatment priorities.

Side-by-side framework

FactorFinasterideRezūm
TypeDaily prescription medicationProcedure
Main BPH actionReduces DHT and prostate growthRelieves obstruction through a procedural mechanism
TimelineGradualProcedure-specific recovery and improvement timeline
PSA effectLowers PSADoes not create the same 5-ARI PSA effect
Sexual trade-offsED/libido/ejaculate effects possibleProcedure-specific; discuss ejaculation and erection outcomes
Daily medication dependenceYes while treatment continuesNo for the procedural effect itself

When a procedure discussion becomes more relevant

A procedure becomes more relevant when medication has not provided adequate symptom control, side effects are unacceptable, retention or other complications develop, or the patient prefers a procedural strategy after understanding candidacy and trade-offs.

NIDDK notes that minimally invasive and surgical treatment can be considered when medicines are ineffective, symptoms are severe or complications occur.

Do not reduce the decision to ejaculation alone

Sexual outcomes matter, but they should be discussed alongside symptom relief, durability, retreatment risk, prostate anatomy and recovery. Ask the urologist specifically about erectile function, ejaculation, catheter use, short-term urinary irritation and likelihood of needing additional treatment later.

Questions to discuss with your clinician

  • What was the main reason finasteride was chosen for me: prostate size, progression risk, urinary symptoms, or a combination?
  • How long should we give this treatment before deciding whether the benefit is adequate?
  • How should my PSA be interpreted while I am taking finasteride, and what change would trigger further evaluation?
  • If side effects or persistent symptoms are a problem, which alternatives preserve the benefits I still need?

Frequently asked questions

Does choosing a procedure mean finasteride should be stopped immediately?

No. Medication changes around a procedure should follow the treating urologist’s instructions.

Is the procedure automatically better because it is more invasive?

No. Invasiveness does not equal suitability. The decision depends on anatomy, severity, goals and trade-offs.

Will a procedure preserve ejaculation?

That depends on the exact procedure and individual anatomy. Ask for procedure-specific sexual-outcome data rather than assuming.

When should a urologist review persistent BPH symptoms?

Review is appropriate when symptoms remain bothersome despite treatment, medication side effects are difficult, urinary retention occurs or the person is considering a procedural option.

Should I stop finasteride if I think I have a side effect?

Do not stop a prescription medication solely on the basis of an online article. Contact the prescriber to review severity, timing, other possible causes and reasonable alternatives.

Can finasteride and tamsulosin be used together?

They can be prescribed together in selected men because they work differently. Whether combination therapy makes sense depends on prostate size, symptom burden, progression risk and tolerance.

Does finasteride shrink the prostate?

Finasteride is used in BPH partly because 5-alpha-reductase inhibition can reduce prostate growth and shrink enlarged prostate tissue over time.

Is finasteride appropriate for every man with BPH symptoms?

No. Treatment choice depends on symptom burden, prostate size, PSA, other conditions, current medicines, side-effect priorities and patient preferences.

Does finasteride treat prostate cancer?

Finasteride is not a treatment for prostate cancer. Because it changes PSA levels, prostate-cancer screening and PSA trends require appropriate clinical interpretation.

What should I tell my clinician before a PSA test?

Tell the clinician that you take finasteride, how long you have taken it and whether you have missed doses or recently stopped, because this can affect interpretation.

Can online symptom scores tell me which prescription drug to use?

No. They can help organize questions, but prescription selection requires clinical evaluation and should account for examination findings, medication history and other health factors.

When do urinary symptoms need urgent medical care?

Seek prompt care for inability to urinate, severe lower abdominal pain, fever with urinary symptoms, visible blood in urine, fainting or other severe symptoms.

Sources

Realvigor prioritizes U.S. prescribing information, public-health references and clinical guidelines. Source links open in a new tab.

Medical disclaimer: This page is educational and cannot determine which treatment is right for you. Do not start, stop, restart or change prescription medication without guidance from a qualified healthcare professional. Seek urgent care for inability to urinate, severe lower abdominal pain, fever with urinary symptoms, fainting, chest pain or other severe symptoms.

Related finasteride decisions